TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Emyria Ltd ( (AU:EMD) ) has issued an update.
Emyria Limited has announced a significant expansion of its national presence by exercising an option to establish its first Empax Clinic in Victoria, marking a major milestone in its East Coast expansion. The company has secured exclusive rights to roll out Empax clinics across Avive Health’s network, enhancing its ability to provide intensive mental-health services nationwide. This expansion is supported by a successful $8 million institutional placement, which will accelerate the development of new sites and expand the clinical workforce. Additionally, Emyria has commenced revenue generation at its Brisbane clinic and has received support from the Department of Veterans’ Affairs for medication-assisted therapy, establishing a dual reimbursement pathway with private insurers.
More about Emyria Ltd
Emyria Limited is a leader in delivering evidence-based intensive mental-health care. The company focuses on providing structured, insurer-supported mental health treatments and has a strategic partnership with Avive Health to expand its clinic network across Australia.
Average Trading Volume: 4,233,375
Technical Sentiment Signal: Buy
Current Market Cap: A$44.16M
See more insights into EMD stock on TipRanks’ Stock Analysis page.